augment maturational effects and, in addition, augment monokine production. The specificity of the interaction is further demonstrated by the lack of augmentation of monokine production with 13,25-dihydroxyvitamin D3 in the presence of lymphokine. These interactions of a classical hormone and the hormonelike product(s) of the immune system with U937 cells serve as a model for human monocyte/macrophage differentiation and suggest a role for these interactions in some aspects of inflammation.
Introduction
The effects of the hormone, 1a25-dihydroxyvitamin D3 (la, 25 [OH]2D3)' are primarily on cells in intestine, bone, and kidney (1) (2) (3) . Specific cytosolic receptors for 1a,25(OH)2D3 are found in these cells as well as cells from several other normal (3, 4) and neoplastic (5, 6) tissues. The significance of 1 a,25(OH)2D3 receptors in tissues other than intestine, bone, or kidney, however, has not been established. Recently, several investigators reported effects of 1a,25(OH)2D3 on cellular replication and differentiation. 1 a,25(OH)2D3 receptors are present in human melanoma cell lines and the addition of hormone to the culture medium caused a dose-dependent decrease in their rate of growth (7) . Abe et al. (8) demonstrated maturation of the murine M-1 cell line towards mature macrophages, while Miyaura et al. (9) induced the human myeloid cell line HL-60 to differentiate into granulocytes with la,25(OH)2D3 . lIa,25(OH)2D3 either stimulated or inhibited proliferation of ROS 17/2.8 rat osteoblastic osteosarcoma cells depending upon the state of maturation of the cells (10) . A concentration-dependent biphasic effect of la,25(OH)2D3 on cell growth was demonstrated to a greater extent when the ROS 17/2.8 cells were cultured in serum-free medium (I1). That these in vitro observations may have biological significance in vivo was suggested by three recent communications. The first, reported by Bar-Shavit et al. (12) noted that macrophages from vitamin D3-deficient mice functioned abnormally and that the defect was corrected by 1Ia,25(OH)2D3 repletion in vitro and in vivo. The second dealt with another mouse model in which vitamin Ddeficient animals were thyroparathyroidectomized and given exogenous 1,25(OH)2D3, which increased osteoclast activity and numbers in the absence of parathyroid hormone (13) . The third extended the observations on the in vitro differentiation of Ml cells by demonstrating prolonged survival of Ia,25(OH)2D3-treated mice inoculated with Ml cells (14) .
We have studied monocyte products and their role in the tissue destruction accompanying inflammatory processes and have recently utilized a human monocyte cell line, U937, originally described by Sundstrbm and Nilsson (15) . The cells possess monocyte characteristics such as Fc receptors, nonspecific esterase staining, phagocytosis of latex beads, and secretion of lysozyme (16) . Upon exposure to crude lymphokine the cells exhibit increased Fc receptors and increased antibody-dependent cellular cytotoxicity (17) (18) (19) . They develop receptors for the chemotactic tripeptide N-formyl-methionyl-leucyl-phenylalanine, in association with directional migration (20), as well as an enhanced ability to kill intracellular pathogens (21) . We have demonstrated that a soluble factor of M, -45-60,000 from lectin-stimulated cloned human T lymphocytes when incubated with U937 cells induces production of mononuclear cell factor (22) and lymphocyte-activating factor activities (23), (Amento, E. P., J. T. Kurnick, and S. M. Krane. Manuscript submitted for publication) which are ascribed to interleukin 1. We have also observed that the U937 cells possess specific high affinity cytosolic receptors for 1a,25(OH)2D3 (24, 25) . We therefore asked whether 1 a,25(OH)2D3 would have specific effects on the differentiation and function of U937 cells either alone or in conjunction with the lymphokine produced by T lymphocytes.
We now report that 1a,25(OH)2D3 causes changes in the shape, adherence, Fc receptor number, and surface antigen expression of U937 cells consistent with a maturational event. These changes are not accompanied by monokine secretion. The addition of 1 a,25(OH)2D3 to lymphokine-stimulated U937 cells, however, augments monokine production.
Methods
Cell culture. U937 cells (kindly provided by Dr. R. Synderman, Duke University Medical Center) were grown in stationary suspension culture in Iscove's modified Dulbecco's medium (Gibco Laboratories, Grand Island, NY), which contained 10% fetal calf serum (Bioproducts, Inc., Warrenton, OR), 50 ;,M 2-mercaptoethanol, 100 U/ml penicillin, and 100 ug/ml streptomycin (Gibco Laboratories) (complete medium) at 37°C in a humidified atmosphere of 5% CO2 and 95% air.
T lymphocytes and their lectin-stimulated soluble factor were obtained as previously described (22) . Briefly, normal human peripheral blood lymphocytes were exposed to tetanus toxoid (1 floculation unit/ml) (State of Massachusetts), and proliferating cells separated on Percolldensity gradients (26) and maintained in culture with interleukin 2 (T cell growth factor)-containing medium. Periodic reexposure to tetanus toxoid and antigen-presenting cells was necessary to maintain interleukin 2 responsiveness and to assure expansion of the antigen-specific T lymphocyte population (27) . Flow cytometer analysis (Ortho Spectrum III, Ortho Diagnostic Systems, Inc., Westwood, MA) using fluoresceinated monoclonal anti-T lymphocyte subset reagents showed that all of the cells expressed the T3, T4, and T 11 a surface antigens and were negative for OKT8 binding (kindly provided by Ortho Pharmaceutical, Raritan, NJ).
T lymphocytes (all OKT4 positive) were washed free oftheir growthsupporting medium and resuspended at a density of 5 Mononuclear cell factor assays. Cell-free supernates of stimulated U937 cells were either used immediately or frozen at -20'C until assayed. Mononuclear cell factor assays were performed as previously described (22) . Briefly, synovial tissue from patients with rheumatoid arthritis was obtained duringjoint surgery. After enzymatic dispersion ofthe synovial lining cells, the adherent cell population was prepared and maintained in culture as described (30) . Before bioassay, adherent synovial cells were removed with trypsin (trypsin-EDTA, Gibco Laboratories) and placed in 24-well trays at 5 X 104 cells/well. Supernatant medium from stimulated U937 cells and control samples was then diluted 1:5 in Dulbecco's modified Eagle's medium (Gibco Laboratories), which contained 10% fetal calf serum, penicillin/streptomycin and incubated with the adherent synovial cells for 3 d. Prostaglandin E2 (PGE2) production from the synovial cells was determined by radioimmunoassay (31) (the antibody to PGE2 was generously provided by Dr. L. Levine, Brandeis University).
Results 1a,25(0H)2D3 effects upon U937 cell proliferation. U937 cells proliferate in complete medium with a doubling time of -27 h. At an initial culture density of I X I05 cells/ml, maximum cell density of 1.25 X 106/ml was attained within 6 d. In suspension culture the cells had a pleomorphic appearance with numerous projections. When maximum cell density was reached and exhaustion of nutrient occurred, the cells rounded up and remained viable for 1-2 d before undergoing rapid cell death. The addition of la,25(OH)2D3 to U937 cells in complete medium caused a dose-dependent decrease in cell proliferation. In the presence of 10% fetal calf serum, inhibition of cell proliferation was apparent at 10-8 M 1 a,25(OH)2D3 (1.17 X 105cells/ ml vs. U937 cells alone at 2.4 X 10 cells/ml after 48 h of incubation). In addition, the physical appearance of the cells was altered. They adhered to, and spread on, the plastic culture dishes. The changes were similar to those seen when U937 cells were incubated with conditioned medium from lectin-stimulated T lymphocytes. The changes were subtle at 10-9 M, but readily apparent at 1 and 2 X 10-8 M (Fig. 1 (Fig. 1) . Although lymphocyte-conditioned medium or la,25(OH)2D3 alone caused the cells to adhere, this effect was not pronounced at the concentrations chosen. However, the combination of lymphocyteconditioned medium and la,25(OH)2D3 produced a marked increase in adherence, which required scraping to transfer cells. Ja,25(OH)2D3 effects in defined medium. In our studies described thus far, the effects of Ia,25(OH)2D3 were examined in the presence of 10% fetal calf serum. The presence of serum with its vitamin D3-binding protein reduces the effective concentration of I a,25(OH)2D3 in the culture medium. To observe the influence of the hormone in the absence of vitamin D3-binding protein, bovine serum albumin (6 mg/ml) and transferrin (5 gg/ml) were substituted for serum in order to increase the free la,25(OH)2D3 available to the cell.
Altered cell shape, increased adherence, and decreased cell proliferation were observed with 10" M la,25(OH)2D3 and for the first time with 25(OH)D3 at 10-9 M. The effect of vitamin D3 metabolites on cell proliferation was demonstrable in serumfree medium at a lower concentration than in medium that contained 10% fetal calf serum. This effect of the hormone was further enhanced in the presence of albumin and transferrin ( Effects of Ja,25(OH)2D3 on cell maturation as evaluated by the detection of monocyte-related surface antigens and Fc receptors. We previously observed that the cell membrane changes that occurred when U937 cells were incubated with medium from lectin-stimulated T lymphocytes included, among others, increased numbers of Fc receptors and increased binding of monoclonal antibodies that defined monocyte-related surface antigens (29) . A similar change was found when U937 cells were incubated with a,25(OH)2D3 in the presence or absence of fetal calf serum (Fig. 3) hormone to U937 cells cultured with a low stimulatory concentration of lymphocyte-conditioned medium caused a marked increase in Fc receptors and OKM 1 binding (Fig. 3, A-D) .
The OKM1 antibody defines a cell surface antigen found on monocytes, granulocytes, and natural killer cells (32) . We previously showed that the OKM 1 antibody defines a monocyterelated antigen on U937 cells (29) . To further clarify the antigen expression on the cell membrane of U937 cells incubated with binds to 80-90% of peripheral blood monocytes and fluid macrophages. In contrast to OKM 1 it exhibits minimal binding to granulocytes and does not bind to null cells (33). Leu M-3 did not bind to U937 cells before stimulation (Fig. 4 A) ; however, when U937 cells were incubated with 1 a,25(OH)2D3 (10-8 M) a shift in fluorescence intensity was detected as demonstrated by an increase in median fluorescence from 10 to 17, signifying the expression of a new surface antigen (Fig. 4 B) . The addition ofhormone to U937 cells cultured together with a substimulatory concentration of lymphocyte-conditioned medium, caused a marked increase in Leu M-3 binding (Fig. 4 D) . These data Effects of Ja,25(0H)2D3 and lymphokine on mononuclear cellfactor production by U937 cells. Medium from U937 cells incubated with la,25(OH)2D3 in the presence of either 10% fetal calf serum, conditioned medium from phytohemagglutininstimulated T lymphocytes, or a combination of conditioned medium and hormone was then assayed for mononuclear cell factor activity (Table II) . Although I a,25(OH)2D3 caused changes in U937 cells similar to those observed with T lymphocyteconditioned medium, no mononuclear cell factor activity was demonstrable when U937 cells were incubated with la,25(OH)2D3 alone. The addition of la,25(OH)2D3 together with conditioned medium from lectin-stimulated T lymphocytes, however, augmented monokine production by the U937 cells.
25(OH)D3 at 10-7 M, in the presence of 10% fetal calf serum, did not potentiate monokine production by U937 cells stimulated with T lymphocyte-conditioned medium. In a parallel experiment, after 8 d of incubation neither 25(OH)D3 (10-7 M) nor 1f3,25(OH)2D3 (10-8 M) augmented mononuclear cell factor production by U937 cells exposed to T lymphocyte-conditioned medium (Table III) .
Discussion
We have demonstrated that la,25(OH)2D3 causes concentrationdependent alterations in U937 cells consistent with monocyte maturation. In addition to changes in cell shape and adherence properties, the hormone causes decreases in proliferation, increases in Fc receptors, and in the expression of monocyterelated surface antigens. These changes are similar to those in our previous observations using conditioned medium from lectin-stimulated cloned T lymphocytes (both OKT4 and OKT8 positive), 100% OKT4 positive noncloned T lymphocytes, and peripheral blood T lymphocytes (22, 29) . Monokine production as assayed by stimulation of PGE2 production from adherent rheumatoid synovial cells, however, is not induced by 1 a,25(OH)2D3 alone, but the presence of la,25(OH)2D3 in combination with conditioned medium from lectin-stimulated T lymphocytes augments mononuclear cell factor production. The effects of la,25(0H)2D3 on the U937 cell are probably mediated through a specific cytosolic receptor, since 1#,25(OH)2D3 was not capable of altering U937 cells nor augmenting mononuclear cell factor production. periments were performed with a defined medium of albumin and transferrin. We reasoned that cells outside of the vascular compartment were not in serum and therefore the concentration offree 1 a,25(OH)2D3 was presumably greater in the extravascular space. In tissue culture, at any total concentration of la,25(OH)2D3 the concentration of free la,25(OH)2D3 would be greater in the system utilizing albumin and transferrin rather than 10% fetal calf serum. Indeed, in the absence of serum, changes in cell morphology and decreases in cell proliferation are seen with lIa,25(OH)2D3 at 10-"-10-'o M. Measurements of cell proliferation in serum-free medium or in a defined medium containing albumin and transferrin demonstrate a 200-300-fold greater effectiveness of la,25(OH)2D3 vs. 25(OH)D3 in stimulating maturation of U937 cells as assessed by decreases in cell division. These changes occur at concentrations of the active hormone that are within the physiological range (10-'°-10" M). The difference in efficacy between the two active vitamin D3 metabolites is consistent with their biological potency.
Mononuclear cell factor shares structural and functional homologies with lymphocyte-activating factor (or interleukin 1). Purified murine lymphocyte-activating factor has mononuclear cell factor activity, and conversely mononuclear cell factor from human peripheral blood monocytes is active in lymphocyte-activating factor assays (35) . Subsequent work confirms these observations and demonstrates other activities shared by these substances (36, 37) . We have previously shown that lymphocyte-activating factor activity is not detected in crude medium from T lymphocyte-stimulated U937 cells, although mononuclear cell factor activity is induced. However, both lym- The observations that certain features of monocyte maturation can take place in the absence of induction of monokine production provide an opportunity to explore the nature of the signals involved in these two dissociable events. The T lymphocyte-conditioned medium may contain two distinct activities-one that promotes maturation, the second that stimulates production of monokines. Meltzer (38) has reported that lymphokine-rich supernatant fluids contain both priming and trigger activities when assayed for tumor cytotoxicity on mouse peritoneal macrophages. Studies involving a variety of inducing agents have been performed utilizing the human promyelocytic leukemia cells, . For example, exposure of the cells to dibutryl cyclic AMP causes plasma membrane differentiation without morphological maturation (40) . Recently Olsson et al. (41) have reported that both HL-60 and U937 cells can be primed with retinoic acid to respond to previously substimulatory concentrations of a T lymphocyte-derived differentiation factor or agents that increase cellular cyclic AMP content. It cannot be stated whether or not the effects of Ia,25(OH)2D3 and retinoic acid are mediated through a similar mechanism.
The physiological relevance of the inhibition of cellular replication in U937 cells associated with alterations of surface antigens consistent with cellular differentiation has not yet been determined. However, these changes can be documented in serum-free medium as well as in defined medium at physiologically relevant concentrations of la,25(OH)2D3. In view of our previous findings of a specific cytosolic receptor for lIa,25(OH)2D3 in U937 cells (24, 25) , as well as in peripheral blood monocytes and activated, but not resting T lymphocytes (42) , and the work ofothers (7) (8) (9) (10) (11) (12) (13) (14) , it is likely that this hormone has a role beyond that currently recognized in intestine, bone, and kidney. This possibility is further supported by our observations that interleukin 1 production by lymphokine-stimulated U937 cells is augmented in the presence of I a,25(OH)2D3. Thus, interactions between classical hormones and some of the hormonelike products of cells of the immune system may play a role not only in monocyte differentiation but in aspects of inflammation in general.
